GFAP degradation in TBI: linking novel modified products to astrocyte pathology and patient outcome. - Wanner IB; Halford J; Lopez J; Shen S; Chen Y; Zhao H; Salas C; Loo RO; Robicsek S; Ellingson BM; Gornbein J; Van Meter TE; et al. (Acta neuropathologica communications, 2026)